NASDAQ:TRIB Trinity Biotech Q1 2026 Earnings Results & Report $6.01 +0.63 (+11.71%) Closing price 11/17/2026 04:00 PM EasternExtended Trading$5.71 -0.30 (-4.99%) As of 07:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Trinity Biotech beat analyst expectations on both earnings and revenue in its Q1 2026 results, released June 16, 2026. The company reported EPS of -$6.90 versus the -$9.30 consensus estimate, while revenue of $10.85 million topped the $10.68 million estimate by $168.00 thousand. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2026Report DateJune 16, 2026TimeBefore Market OpensConference Call DateJune 18, 2026Conference Call4:00 PM ET Trinity Biotech EPS ResultsActual EPS-$6.90Consensus EPS -$9.30Beat/MissBeat by +$2.40One Year Ago EPSN/AEPS Beat Rate3 of last 5 quartersTrinity Biotech Revenue ResultsActual Revenue$10.85 millionExpected Revenue$10.68 millionBeat/MissBeat by +$168.00 thousandYoY Revenue GrowthN/AUpcoming EarningsTrinity Biotech's Q2 2026 earnings is estimated for Thursday, December 10, 2026, based on past reporting schedulesConference Call ResourcesSlide DeckPress Release (6-K)Earnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Earnings DocumentsPress Release(6-K) Trinity Biotech Q1 2026 Earnings FAQ Did Trinity Biotech beat earnings estimates for Q1 2026? Trinity Biotech (NASDAQ:TRIB) reported earnings of -$6.90 per share for Q1 2026, beating the consensus estimate of -$9.30. The report was announced on Tuesday, June 16, 2026. What was Trinity Biotech's revenue for Q1 2026? Trinity Biotech reported revenue of $10.85 million for Q1 2026, against a consensus estimate of $10.68 million. When is Trinity Biotech's next earnings date? Trinity Biotech's next earnings date is estimated for Thursday, December 10, 2026. MarketBeat tracks confirmed and estimated earnings dates for Trinity Biotech on the company's earnings history page. Trinity Biotech Earnings HeadlinesTrinity Biotech Amends Credit Agreement, Note and Warrant TermsNovember 12, 2026 | tipranks.comTrinity Biotech Signs Contract With Red Team Investments For AI Data Center Cooling SolutionsSeptember 9, 2026 | rttnews.comYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt death spiral. Interest payments alone now top a trillion dollars a year. The Social Security trust fund is projected to run dry by 2032, which could trigger an automatic 22% cut to benefits. Between 2020 and 2022, the Fed expanded the money supply by 41%. A free 27 page report breaks down these numbers in plain English, including what central banks have been doing with gold.November 18 at 1:00 AM | American Alternative (Ad)Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center InfrastructureSeptember 9, 2026 | finance.yahoo.comTrinity Biotech's Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center InfrastructureSeptember 9, 2026 | globenewswire.comTrinity Issues Updates On Diagnostics Launch; Plans To Regain Nasdaq Compliance By Feb '27August 31, 2026 | rttnews.comSee More Trinity Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Trinity Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Trinity Biotech and other key companies, straight to your email. Email Address About Trinity BiotechTrinity Biotech (NASDAQ:TRIB) is an Irish diagnostics company that develops, manufactures and markets products for point-of-care testing and clinical laboratories. Its offerings include rapid tests for infectious diseases such as HIV, as well as laboratory assays used in areas including diabetes care. The company also provides products for monitoring blood glucose and assessing long-term blood sugar control. Trinity Biotech serves customers in multiple international markets through a combination of direct sales and distribution partners.View Trinity Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?Disney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a BreakoutAmazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its YearThe Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to WatchTyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend InvestorsMongoDB's Biggest Advantage May Be GitLab's Biggest WeaknessMicrosoft's Outage Barely Moved Its Stock, But a Bigger Risk May Be Building Upcoming Earnings NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026)Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.